KARACHI: The Sindh High Court (SHC) on Thursday directed the federal government to decide the price of Panadol, a medicine that is used for relieving fever and pain, in the next four weeks.
The SHC issued the orders after hearing a contempt of court petition filed by the pharmaceutical company. The manufacturer had moved the SHC after the government set aside the court’s earlier orders about raising the price of Panadol.
During the course of the proceedings, the officials of the Drug Regulatory Authority of Pakistan (Drap) apprised the court that the federal government’s node is needed to raise the price of medicines.
At this, the SHC directed the federal government to decide the price of the medicine in the next cabinet meeting and submit a report to the court in this regard.
The Centre’s lawyer admitted that the matter related to the price of Panadol did not come under discussion in the previous cabinet meeting.
In its petition, the pharmaceutical company stated that they purchase raw materials for the medicine in dollars, adding that the cost of the medicine has increased significantly due to the rupee’s continuous fall against the greenback in recent weeks.
The petitioner said that the government is reluctant to increase the price of the medicine.
Research from past 12 months discloses factors that can help people live long, healthy lives
DI Khan district of KP reports fresh case as provincial tally rises to 20
Province has reported highest number of polio cases in 2024 with 27 children diagnosed with crippling disease
South-western province worst-hit by outbreak of crippling disease as 27 polio cases reported from Balochistan alone
Chronic pain lasts more than three months and affects about 30% of world's population
One of the mutations was also seen in another severe case from British Columbia, Canada
